| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative analysis of coverage decisions for outpatient pharmaceuticals: Evidence from Denmark, Norway and Sweden
|
Grepstad, Mari
|
|
2015
|
119 |
2 |
p. 203-211
9 p.
|
artikel
|
| 2 |
A comparative study of the role of disease severity in drug reimbursement decision making in four European countries
|
Franken, Margreet
|
|
2015
|
119 |
2 |
p. 195-202
8 p.
|
artikel
|
| 3 |
A regulatory governance perspective on health technology assessment (HTA) in France: The contextual mediation of common functional pressures
|
Barron, Anthony J.G.
|
|
2015
|
119 |
2 |
p. 137-146
10 p.
|
artikel
|
| 4 |
Babies in waiting: Why increasing the IVF age cut-off might lead to fewer wanted pregnancies in the presence of procrastination
|
Dolan, Paul
|
|
2015
|
119 |
2 |
p. 174-179
6 p.
|
artikel
|
| 5 |
Compulsory private complementary health insurance offered by employers in France: Implications and current debate
|
Franc, Carine
|
|
2015
|
119 |
2 |
p. 111-116
6 p.
|
artikel
|
| 6 |
Contents
|
|
|
2015
|
119 |
2 |
p. iv-v
nvt p.
|
artikel
|
| 7 |
Cost-effectiveness of trastuzumab in metastatic breast cancer: Mainly a matter of price in the EU?
|
Garattini, Livio
|
|
2015
|
119 |
2 |
p. 212-216
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2015
|
119 |
2 |
p. iii-
1 p.
|
artikel
|
| 9 |
Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement
|
Gaultney, Jennifer G.
|
|
2015
|
119 |
2 |
p. 186-194
9 p.
|
artikel
|
| 10 |
Governance of conditional reimbursement practices in the Netherlands
|
Boon, Wouter
|
|
2015
|
119 |
2 |
p. 180-185
6 p.
|
artikel
|
| 11 |
Medicare's use of cost-effectiveness analysis for prevention (but not for treatment)
|
Chambers, James D.
|
|
2015
|
119 |
2 |
p. 156-163
8 p.
|
artikel
|
| 12 |
Medicine price awareness in chronic patients in Belgium
|
Fraeyman, Jessica
|
|
2015
|
119 |
2 |
p. 217-223
7 p.
|
artikel
|
| 13 |
Medicine shortages – A study of community pharmacies in Finland
|
Heiskanen, K.
|
|
2015
|
119 |
2 |
p. 232-238
7 p.
|
artikel
|
| 14 |
Reforming private drug coverage in Canada: Inefficient drug benefit design and the barriers to change in unionized settings
|
O’Brady, Sean
|
|
2015
|
119 |
2 |
p. 224-231
8 p.
|
artikel
|
| 15 |
Social values and health priority setting in Australia: An analysis applied to the context of health technology assessment
|
Whitty, Jennifer A.
|
|
2015
|
119 |
2 |
p. 127-136
10 p.
|
artikel
|
| 16 |
The effects of economic sanctions on disease specific clinical outcomes of patients with thalassemia and hemophilia in Iran
|
Karimi, Mehran
|
|
2015
|
119 |
2 |
p. 239-243
5 p.
|
artikel
|
| 17 |
The use of dental services for children: Implications of the 2010 dental reform in Israel
|
Shahrabani, Shosh
|
|
2015
|
119 |
2 |
p. 117-126
10 p.
|
artikel
|
| 18 |
Using needs-based frameworks for evaluating new technologies: An application to genetic tests
|
Rogowski , Wolf H.
|
|
2015
|
119 |
2 |
p. 147-155
9 p.
|
artikel
|
| 19 |
Value judgments for priority setting criteria in genetic testing: A discrete choice experiment
|
Severin, Franziska
|
|
2015
|
119 |
2 |
p. 164-173
10 p.
|
artikel
|
Tijdschrift beschrijving